Open House - Global Healthcare 2022: Aditxt | Edison Group
Aditxt is a life sciences company developing technologies specifically focused on improving the health of the immune system through immune reprogramming and monitoring.
-
Amro Albanna, Co-Founder, Chairman, and CEO, Aditxt, Inc.
Amro co-founded Aditxt in September 2017, focusing on advancing some of the most promising biotechnologies around the health of the immune system. The company has grown to become a global leader developing a new class of therapeutics designed to retrain the immune system to potentially address organ rejection, autoimmunity, and allergies. Prior to Aditxt, Amro founded multiple companies ranging from promising innovations including nano-sensors for detecting environmental gases, volatile compounds designed to interfere with mosquitoes’ smell neurons responsible for the protection against mosquito-borne diseases, and semiconductor sensors chips combining GPS & wireless technologies. Amro earned his Bachelor of Science Degree in Business Administration and Computer Information Systems from California State University, San Bernardino. He continued his informal education at California State Long Beach and Harvard Medical School (HMX online).
